'Species-metabolism' dual-targeting technology unlocks microbial and enzyme resources
A new technology is poised to transform the discovery of microbial species and enzymes with specific in situ metabolic ...
Dairy Enzyme Market Shaping From Growth To Value: $1.1 Billion By 2031
The Dairy Enzyme market Size was at $574.20 million in 2021, and is estimated to reach $1.1 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031. David Correa Allied Market Research +1 800-792 ...
Longevity Breakthrough: Scientists Restore “Youthful” Enzyme Activity To Combat Aging
Innovative therapies revive a once-undruggable mitochondrial aging regulator through a revolutionary enzyme activation ...
Armed robbery in Revesby2d
Dual-Target Tech Unlocks Microbial, Enzyme Resources
A new technology developed by the Single-Cell Center at Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of ...
Engineered enzyme could transform how essential chemicals and medicines are made
Researchers from the Manchester Institute of Biotechnology and the Department of Chemistry at The University of Manchester ...
technologynetworks13d
Microglia “Spit” Enzymes at Large Alzheimer’s Plaques
Microglia can partially break down amyloid plaques by "spitting" a digestive enzyme at them, a new study has found.
Monthly Prescribing Reference2d
FDA Clears Digestive Enzyme Cartridge RELiZORB for Kids as Young as 1 Year
RELiZORB is a digestive enzyme cartridge designed to hydrolyze fats contained in enteral formulas, mimicking the function of lipase. The Food and Drug Administration (FDA) has expanded the approval of ...
Onco-Innovations' Licensed Technology Shown in Study to Successfully Prevent Regeneration of Cancer Cells
VANCOUVER, BC / ACCESS Newswire / January 16, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ('Onco' or the 'Company') is pleased to provide information on its ...
Synthego Signs Strategic Agreement with AstraZeneca to License CRISPR Gene Editing Enzyme
Synthego, a leading supplier of CRISPR solutions, has entered a strategic licensing agreement with global biopharmaceutical company AstraZeneca. This agreement grants Synthego a global license to ...
Key enzyme identified as potential target for cancer immunotherapy
Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme—P4HA1 prolyl hydroxylase, ...
PharmiWeb9d
Onco-Innovations' Technology Shown in Study to Successfully Inactivate DNA Repair in Cancer, Potentially Boosting Radiation Therapy Effectiveness
VANCOUVER, BC / ACCESSWIRE / January 9, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information on its exclusively-licensed ...